Empirico
Jason O'Rourke is currently the Director of Target Biology at Empirico Inc., after previously holding the position of Director of Pharmacology at SNO Bio, Inc. and Associate Director of In Vivo Pharmacology at Fate Therapeutics Inc. Jason has a background in small molecule drug discovery and regenerative medicine, with experience in leading teams through target identification, compound screening, and validation in both in vitro and in vivo settings. Jason has also conducted research in skeletal muscle and cardiovascular biology during their time as a Postdoctoral Scientist at The University of Texas Southwestern Medical Center at Dallas. Jason holds a Ph.D. in Molecular Genetics from the University of Florida.
This person is not in any teams
Empirico
1 followers
Empirico is a biotechnology company focused on the discovery and development of novel medicines which are designed to mimic naturally-occurring genetic variants that confer beneficial effects on health and disease. Empirico’s two foundational and proprietary technology platforms - the Precision Insights Platform™ for genetically-validated target discovery and siRCH™ for the discovery and development of siRNA medicines - are used separately and in tandem to enable Empirico and our collaborators from the discovery and validation of novel targets to the development of clinically-viable therapeutics. Empirico’s exceptional internal capabilities, augmented by those of its partners, are driving the advancement of a growing and differentiated pipeline of wholly-owned and partnered programs. Empirico is headquartered in San Diego, CA with a major second site in Madison, WI.